Our results revealed that HNMT upregulation in NSCLC cells leads to HER2 upregulation, which in turn increases tumorigenicity and chemoresistance through CSCs maintenance and antioxidant properties. Here, ERBB2 is linked to non-small cell lung carcinoma.